A citation-based method for searching scientific literature

Yi-Min Liu, Kunal Nepali, Jing-Ping Liou. J Med Chem 2017
Times Cited: 75







List of co-cited articles
521 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Idiopathic pulmonary fibrosis.
Luca Richeldi, Harold R Collard, Mark G Jones. Lancet 2017
700
22

An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
21

Idiopathic pulmonary fibrosis.
Talmadge E King, Annie Pardo, Moisés Selman. Lancet 2011
17

Pathogenesis of idiopathic pulmonary fibrosis.
Paul J Wolters, Harold R Collard, Kirk D Jones. Annu Rev Pathol 2014
445
17

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
670
17

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
16

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
14

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
14

The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller, Kjetil Ask, David Warburton, Jack Gauldie, Martin Kolb. Int J Biochem Cell Biol 2008
628
13

Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
T Ashcroft, J M Simpson, V Timbrell. J Clin Pathol 1988
10

The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak.
Andrew M Tager, Peter LaCamera, Barry S Shea, Gabriele S Campanella, Moisés Selman, Zhenwen Zhao, Vasiliy Polosukhin, John Wain, Banu A Karimi-Shah, Nancy D Kim,[...]. Nat Med 2008
535
9

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
9


Oxidative stress and pulmonary fibrosis.
Paul Cheresh, Seok-Jo Kim, Sandhya Tulasiram, David W Kamp. Biochim Biophys Acta 2013
259
8


Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
979
8


Idiopathic pulmonary fibrosis.
Fernando J Martinez, Harold R Collard, Annie Pardo, Ganesh Raghu, Luca Richeldi, Moises Selman, Jeffrey J Swigris, Hiroyuki Taniguchi, Athol U Wells. Nat Rev Dis Primers 2017
461
8

Discovery, Structure-Activity Relationship, and Binding Mode of an Imidazo[1,2-a]pyridine Series of Autotaxin Inhibitors.
Agnès Joncour, Nicolas Desroy, Christopher Housseman, Xavier Bock, Natacha Bienvenu, Laëtitia Cherel, Virginie Labeguere, Christophe Peixoto, Denis Annoot, Luce Lepissier,[...]. J Med Chem 2017
33
18

Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease.
Ana L Mora, Mauricio Rojas, Annie Pardo, Moises Selman. Nat Rev Drug Discov 2017
161
8


Global incidence and mortality of idiopathic pulmonary fibrosis: a systematic review.
John Hutchinson, Andrew Fogarty, Richard Hubbard, Tricia McKeever. Eur Respir J 2015
414
8

Incidence and prevalence of idiopathic pulmonary fibrosis: review of the literature.
Luba Nalysnyk, Javier Cid-Ruzafa, Philip Rotella, Dirk Esser. Eur Respir Rev 2012
303
6

Antifibrotic and anti-inflammatory activity of the tyrosine kinase inhibitor nintedanib in experimental models of lung fibrosis.
Lutz Wollin, Isabelle Maillet, Valérie Quesniaux, Alexander Holweg, Bernhard Ryffel. J Pharmacol Exp Ther 2014
351
6

Myofibroblast contraction activates latent TGF-beta1 from the extracellular matrix.
Pierre-Jean Wipff, Daniel B Rifkin, Jean-Jacques Meister, Boris Hinz. J Cell Biol 2007
896
6

BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.
Frank Hilberg, Gerald J Roth, Martin Krssak, Susanna Kautschitsch, Wolfgang Sommergruber, Ulrike Tontsch-Grunt, Pilar Garin-Chesa, Gerd Bader, Andreas Zoephel, Jens Quant,[...]. Cancer Res 2008
733
6

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.
M Dominici, K Le Blanc, I Mueller, I Slaper-Cortenbach, Fc Marini, Ds Krause, Rj Deans, A Keating, Dj Prockop, Em Horwitz. Cytotherapy 2006
6


Idiopathic pulmonary fibrosis: an update.
Paolo Spagnolo, Nicola Sverzellati, Giulio Rossi, Alberto Cavazza, Argyris Tzouvelekis, Bruno Crestani, Carlo Vancheri. Ann Med 2015
76
6

Oxidative stress in pulmonary fibrosis: a possible role for redox modulatory therapy.
Vuokko L Kinnula, Cheryl L Fattman, Roderick J Tan, Tim D Oury. Am J Respir Crit Care Med 2005
293
6

A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation.
James Gierse, Atli Thorarensen, Konstantine Beltey, Erica Bradshaw-Pierce, Luz Cortes-Burgos, Troii Hall, Amy Johnston, Michael Murphy, Olga Nemirovskiy, Shinji Ogawa,[...]. J Pharmacol Exp Ther 2010
163
6

Idiopathic pulmonary fibrosis: pathogenesis and management.
Giacomo Sgalla, Bruno Iovene, Mariarosaria Calvello, Margherita Ori, Francesco Varone, Luca Richeldi. Respir Res 2018
201
6

Idiopathic Pulmonary Fibrosis (IPF): An Overview.
Shaney L Barratt, Andrew Creamer, Conal Hayton, Nazia Chaudhuri. J Clin Med 2018
116
6

Nintedanib: from discovery to the clinic.
Gerald J Roth, Rudolf Binder, Florian Colbatzky, Claudia Dallinger, Rozsa Schlenker-Herceg, Frank Hilberg, Stefan-Lutz Wollin, Rolf Kaiser. J Med Chem 2015
161
6

Cellular senescence mediates fibrotic pulmonary disease.
Marissa J Schafer, Thomas A White, Koji Iijima, Andrew J Haak, Giovanni Ligresti, Elizabeth J Atkinson, Ann L Oberg, Jodie Birch, Hanna Salmonowicz, Yi Zhu,[...]. Nat Commun 2017
665
6

TOLLIP, MUC5B, and the Response to N-Acetylcysteine among Individuals with Idiopathic Pulmonary Fibrosis.
Justin M Oldham, Shwu-Fan Ma, Fernando J Martinez, Kevin J Anstrom, Ganesh Raghu, David A Schwartz, Eleanor Valenzi, Leah Witt, Cathryn Lee, Rekha Vij,[...]. Am J Respir Crit Care Med 2015
176
5

Exploration of a potent PI3 kinase/mTOR inhibitor as a novel anti-fibrotic agent in IPF.
Paul F Mercer, Hannah V Woodcock, Jessica D Eley, Manuela Platé, Michal G Sulikowski, Pascal F Durrenberger, Linda Franklin, Carmel B Nanthakumar, Yim Man, Federica Genovese,[...]. Thorax 2016
117
5

Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis.
Roderick J Phillips, Marie D Burdick, Kurt Hong, Marin A Lutz, Lynne A Murray, Ying Ying Xue, John A Belperio, Michael P Keane, Robert M Strieter. J Clin Invest 2004
781
5

The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.
Phillip L Molyneaux, Michael J Cox, Saffron A G Willis-Owen, Patrick Mallia, Kirsty E Russell, Anne-Marie Russell, Elissa Murphy, Sebastian L Johnston, David A Schwartz, Athol U Wells,[...]. Am J Respir Crit Care Med 2014
317
5

Pulmonary fibrosis: pathogenesis, etiology and regulation.
M S Wilson, T A Wynn. Mucosal Immunol 2009
480
5

Idiopathic Pulmonary Fibrosis: A Genetic Disease That Involves Mucociliary Dysfunction of the Peripheral Airways.
Christopher M Evans, Tasha E Fingerlin, Marvin I Schwarz, David Lynch, Jonathan Kurche, Laura Warg, Ivana V Yang, David A Schwartz. Physiol Rev 2016
132
5

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
976
5

TGF-β: the master regulator of fibrosis.
Xiao-Ming Meng, David J Nikolic-Paterson, Hui Yao Lan. Nat Rev Nephrol 2016
5

Diverse functions of matrix metalloproteinases during fibrosis.
Matthew Giannandrea, William C Parks. Dis Model Mech 2014
306
5

NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
Louise Hecker, Ragini Vittal, Tamara Jones, Rajesh Jagirdar, Tracy R Luckhardt, Jeffrey C Horowitz, Subramaniam Pennathur, Fernando J Martinez, Victor J Thannickal. Nat Med 2009
607
5

Pirfenidone in idiopathic pulmonary fibrosis.
H Taniguchi, M Ebina, Y Kondoh, T Ogura, A Azuma, M Suga, Y Taguchi, H Takahashi, K Nakata, A Sato,[...]. Eur Respir J 2010
647
5

Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis.
Hillary Loomis-King, Kevin R Flaherty, Bethany B Moore. Curr Opin Pharmacol 2013
64
6

Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects.
Luis A Ortiz, Frederica Gambelli, Christine McBride, Dina Gaupp, Melody Baddoo, Naftali Kaminski, Donald G Phinney. Proc Natl Acad Sci U S A 2003
5

Bleomycin in the setting of lung fibrosis induction: From biological mechanisms to counteractions.
Veronica Della Latta, A Cecchettini, S Del Ry, M A Morales. Pharmacol Res 2015
207
5

Bone marrow-derived mesenchymal stem cells in repair of the injured lung.
Mauricio Rojas, Jianguo Xu, Charles R Woods, Ana L Mora, Willy Spears, Jesse Roman, Kenneth L Brigham. Am J Respir Cell Mol Biol 2005
606
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.